Reach Us +1-217-403-9671
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Potential Therapeutic Agent In Psychiatric And Neurological Diseases: Alpha Lipoic Acid

Alpha lipoic acid (ALA) which is known by its antioxidant properties can lead to positive reflections through various mechanisms of action in nervous system diseases. ALA can create privileges in the treatment of neurological and psychiatric diseases through the vital features such as prevention of formation of reactive oxygen species (ROS), having a mission as a cofactor in various enzyme complexes, promotion the level of antioxidants and neurotransmitters in brain. It has also been shown to be responsible for regulation the nerve growth factor, prevention of neuronal damage and neuronal loss, and vitalization of damaged tissues. Hence, the implementation of ALA as a therapeutic substance in the therapy of neurological and psychiatric diseases is promising in the treatment of diseases. Finally, ALA can prevent diseases related with nervous system.


Author(s):

Hande Çekici and Yunus Emre Bakırhan



Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+

Recommended Conferences

  • Psychiatrists and Psychologists
    June 10-11, 2019 Berlin, Germany
  • Mental Health
    June 13th - 15th 2019 Amsterdam, Netherlands
  • Down Syndrome, Autism & Cerebral Palsy
    Oct 21-22, 2019 Tokyo, Japan
  • Public Mental Health and Neuroscience
    December 09-10, 2019 Dubai, UAE
Flyer image

Abstracted/Indexed in

  • Index Copernicus
  • Google Scholar
  • CiteFactor
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat
  • Publons
  • Serials Union Catalogue (SUNCAT)
  • Geneva Foundation for Medical Education and Research
  • Secret Search Engine Labs